JP Morgan Chase’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-169,000
Closed -$5.04M 4515
2014
Q3
$5.04M Sell
169,000
-7,071,976
-98% -$150M ﹤0.01% 2371
2014
Q2
$145M Hold
7,240,976
0.04% 468
2014
Q1
$197M Hold
7,240,976
0.05% 369
2013
Q4
$150M Hold
7,240,976
0.04% 419
2013
Q3
$132M Buy
+7,240,976
New +$131M 0.04% 451

Other funds holding AUXL

JP Morgan Chase's AUXL Position: Q4 2014 in Review

JP Morgan Chase sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014, closing a stake of 133,882 shares — an estimated $4M sold.

JP Morgan Chase first reported a position in AUXL in Q2 2013 and held it in 6 quarters. The position peaked at $5.8M in Q1 2014. 158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

  • JP Morgan Chase reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • JP Morgan Chase sold 133,882 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2014, an estimated $4M.
  • JP Morgan Chase first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • JP Morgan Chase's AUXILIUM PHARAMCEUTICALS INC position peaked at $5.8M in Q1 2014.
  • 158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on JP Morgan Chase's 13F filing for Q4 2014, filed 13 Feb 2015.